Oral sustained release formulation of tedisamil with gastric...

Details Oral sustained release formulation of tedisamil with gastric... Oral sustained release formulation of tedisamil with gastric...

A - Human Necessities

61

K

A61K 9/20 (2006.01) A61P 9/06 (2006.01)

Patent

CA 2569919

The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia.

L'invention concerne une nouvelle formulation à libération prolongée à propriétés de rétention gastrique comprenant du tédisamil ou un sel de celui-ci pharmaceutiquement acceptable, ainsi que son utilisation dans la prévention et le traitement de fibrillation auriculaire, du flutter auriculaire et de l'ischémie cardiaque.

Affiliated with

Also associated with

Rating

Oral sustained release formulation of tedisamil with gastric... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral sustained release formulation of tedisamil with gastric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral sustained release formulation of tedisamil with gastric... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1754213